Metastatic Colorectal cancer (mCRC)
Conditions
Brief summary
Progression Free Survival (PFS): as the time from C1D1 (in part 1) or randomization (in part 2) into the study to time of progression of the disease or death from any cause, whatever occurs first.
Detailed description
Overall Survival (OS): as time from C1D1 (in part 1) or randomization (in part 2) until death or end of study (EOS)., Overall Response rate (ORR): Partial Response (PR) or Complete Response (CR), Disease Control Rate (DCR): Complete Response (CR), Partial Response (PR) or Stable Disease (SD), Duration of Response (DOR): as time from achievement of PR/CR until recurrence or progression of the disease or death from any cause
Interventions
Sponsors
Universitaetsklinikum Heidelberg AöR
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression Free Survival (PFS): as the time from C1D1 (in part 1) or randomization (in part 2) into the study to time of progression of the disease or death from any cause, whatever occurs first. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival (OS): as time from C1D1 (in part 1) or randomization (in part 2) until death or end of study (EOS)., Overall Response rate (ORR): Partial Response (PR) or Complete Response (CR), Disease Control Rate (DCR): Complete Response (CR), Partial Response (PR) or Stable Disease (SD), Duration of Response (DOR): as time from achievement of PR/CR until recurrence or progression of the disease or death from any cause | — |
Countries
Germany
Outcome results
None listed